• Users Online: 152
  • Print this page
  • Email this page


 Full text articles
CASE REPORTS  
Toxic epidermal necrolysis during cotherapy with ipilimumab and nivolumab
Shelby L Kubicki, Macartney E Welborn, Anisha B Patel
[ABSTRACT]  [HTML FULL TEXT]  [PDF]
Pyoderma gangrenosum following initiation of immune checkpoint inhibitor therapy
Macartney E Welborn, Shelby L Kubicki, Anisha B Patel
[ABSTRACT]  [HTML FULL TEXT]  [PDF]
REVIEW ARTICLES Top
Cardiotoxicity of FDA-approved immune checkpoint inhibitors: A rare but serious adverse event
Abdulrazzak Zarifa, Mohammed Salih, Juan Lopez-Mattei, Hun Ju Lee, Cezar Iliescu, Saamir Hassan, Nicolas Palaskas, Jean-Bernard Durand, Elie Mouhayar, Joseph Kim, Peter Kim
[ABSTRACT]  [HTML FULL TEXT]  [PDF]
Personalized cancer immunotherapy: Today's challenge and tomorrow's promise
Malaka Ameratunga, Wen Xu, Juanita Lopez
[ABSTRACT]  [HTML FULL TEXT]  [PDF]


 Coming soon

EDITORIAL
1.  Being realistic and optimistic in curing cancer
REVIEW ARTICLE
1.  ERK Inhibitors in Oncology Clinical Trials